APNHF (Aspen Pharmacare Holdings) Short-Term Debt: $214 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

APNHF Aspen Pharmacare Holdings Ltd APNHF
62 GF Score
Price $8.70
GF Value $9.49
Valuation Fairly Valued
! 10 Warning Signs
View Full Analysis

What is Aspen Pharmacare Holdings Short-Term Debt?

Aspen Pharmacare Holdings APNHF -1.18% 62 Short-Term Debt is $214 Mil as of Dec. 2025. GuruFocus rates APNHF with a GF Score™ of 62/100 and a GF Value™ of $9.49 (Fairly Valued). The stock has 10 warning signs investors should review.

Aspen Pharmacare Holdings's Short-Term Debt for the quarter that ended in Dec. 2025 was $214 Mil.

Aspen Pharmacare Holdings's quarterly Short-Term Debt declined from Dec. 2024 ($251 Mil) to Jun. 2025 ($244 Mil) and declined from Jun. 2025 ($244 Mil) to Dec. 2025 ($214 Mil).

Aspen Pharmacare Holdings's annual Short-Term Debt increased from Jun. 2023 ($413 Mil) to Jun. 2024 ($599 Mil) but then declined from Jun. 2024 ($599 Mil) to Jun. 2025 ($244 Mil).

Aspen Pharmacare Holdings Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Aspen Pharmacare Holdings Short-Term Debt Related Terms

Aspen Pharmacare Holdings Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Aspen Pharmacare Holdings's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aspen Pharmacare Holdings Short-Term Debt Chart

Aspen Pharmacare Holdings Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,756.69 729.78 413.13 599.05 244.45

Aspen Pharmacare Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 622.50 599.05 251.07 244.45 214.23
APNHF
62GF Score
Aspen Pharmacare Holdings Ltd APNHF
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $214 Mil mean?
Aspen Pharmacare Holdings (APNHF) has a Short-Term Debt of $214 Mil as of Dec. 2025.
Is Aspen Pharmacare Holdings' Short-Term Debt too high?
Aspen Pharmacare Holdings' current Short-Term Debt is $214 Mil. Overall, Aspen Pharmacare Holdings has a GF Score™ of 62/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Aspen Pharmacare Holdings' Short-Term Debt compare to ZTS and UTHR?
Aspen Pharmacare Holdings' Short-Term Debt of $214 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Drug Manufacturers company?
A good Short-Term Debt depends on the Drug Manufacturers industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Aspen Pharmacare Holdings's current Short-Term Debt is $214 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aspen Pharmacare Holdings stock overvalued right now?
Based on GuruFocus' analysis, Aspen Pharmacare Holdings (APNHF) is currently considered Fairly Valued. The stock's GF Value™ is $9.49, compared to a current price of $8.70 — trading 8.4% below its estimated fair value. The current Short-Term Debt is $214 Mil. Aspen Pharmacare Holdings' overall GF Score™ is 62/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Aspen Pharmacare Holdings (APNHF), the current Short-Term Debt is $214 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aspen Pharmacare Holdings (APNHF) Overvalued in 2026?

Based on GuruFocus' analysis, Aspen Pharmacare Holdings stock appears to be undervalued. The current stock price of $8.70 is trading 8.4% below its estimated GF Value™ of $9.49. GuruFocus considers Aspen Pharmacare Holdings to be Fairly Valued.

Key valuation signals for APNHF:

  • Short-Term Debt: $214 Mil
  • GF Value™: $9.49 vs. price of $8.70 (8.4% below fair value)
  • GF Score™: 62/100 with 10 warning signs

No single metric tells the full story. See the APNHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aspen Pharmacare Holdings Business Description

Address Douglas Saunders Drive, Aspen Place, 9 Rydall Vale Park, La Lucia Ridge, Durban, NL, ZAF
Aspen Pharmacare Holdings Ltd is a multinational pharmaceutical company. The group focuses on marketing and manufacturing a broad range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets. The business segments of the group are split between the Commercial Pharmaceuticals and Manufacturing segments. The Commercial Pharmaceuticals business segments are: Injectables, Over-the-counter, and Prescription. The Manufacturing business segments are: Active Pharmaceutical Ingredients, Finished Dose Form, and Heparin. Its geographic regions are Africa Middle East, Europe CIS, Australasia, Asia, and America.
62GF Score

Get the complete analysis for APNHF

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.70
Price
$9.49
GF Value